Drug Channels

APRIL 8, 2024

This unique, new event will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. I am pleased to announce the inaugural Drug Channels Leadership Forum !

Pharmaceutical Manufacturing 72

Pharmaceutical Manufacturing 72

The Pharmacist

JULY 4, 2023

Last week (27 June) the Department of Health and Social Care (DHSC) issued a Tier 3 (high impact) medicine […] The post GLP-1 receptor agonists shortage expected until 2025 appeared first on The Pharmacist.

Diabetes 81

Diabetes 81

STAT

APRIL 24, 2024

Instead, the USDA will enforce a limit on added sugars in flavored milk starting in the fall of 2025. The Department of Agriculture announced Wednesday that it has abandoned a previous proposal to restrict the sale of flavored milk in elementary and middle schools. Read the rest…

291

291

Putting Patients First Blog

JANUARY 16, 2024

NHC 2025 Notice of Benefit and Payment Parameters (NBPP) Comments January 16, 2024 Allen Pinn, Coordinator, Policy The National Health Council (NHC) submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding the 2025 Notice of Benefit and Payment Parameters (NBPP) on January 8.

Insurance Coverage and Processing 59

Insurance Coverage and Processing Communication 59

Pharmaceutical Commerce

JANUARY 10, 2024

At the 42nd annual JP Morgan Healthcare Conference, Moderna said new product launches later this year will return the company to sales growth in 2025.

Vaccines 52

Vaccines 52

pharmaphorum

MARCH 13, 2024

Prilenia Therapeutics is planning to file its Huntington’s disease drug pridopidine in the EU shortly, after mixed results in a phase 3 trial.

110

110

pharmaphorum

JULY 8, 2022

That spend is due to reach of $3 billion by 2025, according to GlobalData analyst Kitty Whitney, who notes that there has been a steady stream of startups formed in the last three to four years to tap into the emerging AI market. The post Pharma’s spend on AI in drug discovery ‘could top $3bn by 2025’ appeared first on.

Compounding 129

Compounding 129

Pharmaceutical Technology

DECEMBER 20, 2023

The EC has revoked marketing authorisations for Tecfidera generics, granting the drug marketing protection until February 2025.

52

52

Express Pharma

FEBRUARY 8, 2024

Large pharma organisations are planning to almost double their investment in lab transformation by 2025, to up to 7 per cent of their revenue, up from 4 per cent today. The post Large pharma cos to invest nearly 7 per cent revenue on next-gen labs by 2025: Capgemini report appeared first on Express Pharma.

90

90

Putting Patients First Blog

MARCH 4, 2024

These guidelines should encompass rigorous scrutiny of the impact of the Manufacturer Discount Program on formulary decisions and UM practices, ensuring they support broad access to essential medications within the newly defined standard Part D benefit structure as outlined in the Draft CY 2025 Part D Redesign Program Instructions.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication Hospitals 40

pharmaphorum

AUGUST 24, 2022

The biotech has confirmed it will not launch the biosimilar until March 2025 however, honouring the terms of its 2020 agreement with Alexion that resolved litigation over the validity of patents covering Soliris (eculizumab) in the US.

Biosimilars 90

Biosimilars Labelling 90

Commonwealth Pharmacists Association

SEPTEMBER 1, 2022

CwPAMS 2 Programme (2022 – 2025) Applications are open until the 15th of December 2022 The Tropical Health and Education Trust (THET) and the Commonwealth Pharmacists Association (CPA) are pleased to announce the second round of grants for the CwPAMS scheme CwPAMS is funded by the UK Department of Health and Social Care’s Fleming Fund.

52

52

STAT

MARCH 5, 2024

Experts who advise the Food and Drug Administration on vaccine-related issues voted unanimously on Tuesday to recommend that the FDA approve trivalent flu vaccines for the 2024-2025 season, instead of the quadrivalent, or four-in-one, shots that have been the industry standard for the past decade or so. Read the rest…

Vaccines 309

Vaccines 309

Pharma Mirror

MARCH 31, 2021

Azelis, an innovation service provider, is excited to release its sustainability strategy, ‘Action 2025’, reinforcing its commitment to become the world-leading provider of sustainable solutions and services in the specialty chemicals and food ingredients distribution industry.

52

52

STAT

DECEMBER 8, 2023

On Thursday, the Medicare Payment Advisory Commission reviewed Medicare performance data and concluded that despite doctors’ protests that their pay hasn’t kept up with inflation over the last 20 years, doctors shouldn’t get more than a minor raise for 2025. It also recommended hospitals should get a 1.5%

Hospitals 240

Hospitals 240

Outsourcing Pharma

MARCH 23, 2021

A new report from the organization forecasts a wave of pharma innovation over the next four years could lead to 75 FDA drug approvals annually by 2025.

52

52

STAT

NOVEMBER 27, 2023

That is because many disabled people will no longer be counted as disabled by the new questions the Census is proposing to use starting in 2025 with the annual American Community Survey (ACS). Census Bureau moves forward with changes to disability data collection methods.

358

358

STAT

JANUARY 29, 2024

Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025. While under treatment, patients use the device for one hour per day in their homes.

317

317

STAT

MARCH 25, 2024

Budget officials within the Biden administration started reviewing final payment regulations for 2025 Medicare Advantage plans last week after more than 42,000 public comments rolled into the federal government’s inbox. Those rules will come out no later than April 1.

237

237

pharmaphorum

MARCH 4, 2022

billion) in 2025, twice its earlier forecast. The post Novo Nordisk eyes obesity sales of $3.7bn in 2025 thanks to Wegovy appeared first on.

64

64

Putting Patients First Blog

MARCH 4, 2024

However, we urge CMS to consider the following recommendations to ensure the 2025 policies further align with patient-centered care. Created by and for patient organizations more than 100 years ago, the NHC brings diverse organizations together to forge consensus and drive patient-centered health policy.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication Hospitals 40

STAT

DECEMBER 13, 2023

Starting in 2025, electronic health record vendors who develop or supply these tools, which increasingly use a type of AI known as machine learning, will be required to disclose more technical information to clinical users about their performance and testing, as well as the steps taken to manage potential risks.

Hospitals 317

Hospitals 317

STAT

JANUARY 30, 2024

As envisioned, the agency will negotiate pricing and rebates with the drug manufacturers — Vertex Pharmaceuticals and Bluebird Bio — over the next several months on behalf of an undetermined number of states that, starting in January 2025, will have the option to participate in the program.

320

320

Pharma Mirror

NOVEMBER 10, 2021

The post CPhI Worldwide Report: CMOs will account for four of the five top bio manufacturing capacities in 2025 appeared first on Pharma Mirror Magazine. These new findings are released ahead of the in-person.

52

52

STAT

SEPTEMBER 25, 2023

Further, the Health Resources and Services Administration estimates that by 2025, there will be a shortage of more than 250,000 mental health professionals, including psychiatrists. Nearly 334,000  health care professionals left the workforce in 2021. Read the rest…

Compounding 352

Compounding Hospitals 352

Pharma Mirror

MARCH 10, 2021

The report anticipates breakthroughs in multi-modal disease therapies within five years, mRNA platforms to transform many new non-infectious disease treatment options, and huge growth in contract services due to the recent surge in IND applications – with 75 annual FDA approvals expected by 2025.

52

52

STAT

SEPTEMBER 13, 2023

In connection with the move away from prescription sales, Akili will reduce its workforce by 40%, which the company projects will extend its runway into the second half of 2025.

Labelling 316

Labelling 316

STAT

DECEMBER 21, 2023

If everything proceeds on time, drug and medical device makers will be required to submit plans for meeting diversity standards by the end of March 2025. The FDA is set to draft guidance for those plans by the end of the year. To ensure that drugs work for everyone, they must be tested on a representative sample of people.

Drug Development 295

Drug Development 295

pharmaphorum

APRIL 23, 2024

BenevolentAI is embarking on another round of job losses, closing its US office, and shelving its software-as-a-service business to extend its cash reserves into the third quarter of 2025.

73

73

STAT

OCTOBER 11, 2023

The decision meant that data from roughly half of the trial were scrapped, which delayed their plans to seek regulatory approval for the shot until 2026, instead of 2025. Pfizer and Valneva maintained there were no safety issues or adverse events prompting the decision, and instead blamed unspecified problems with the conduct of the study.

Vaccines 254

Vaccines 254

STAT

NOVEMBER 8, 2023

As the company said it was going to spend more money on research, it also withdrew earnings outlooks for 2025. ” Sanofi unveiled its R&D plans late last month as it announced its third-quarter performance and said that it was spinning out its consumer health division.

Drug Development 303

Drug Development 303

STAT

NOVEMBER 6, 2023

Starting in 2025, brokers cannot accept more than $632, total, for each new Medicare-eligible person they enroll in a Medicare Advantage plan, according to the government’s latest proposed rule.

Health Insurance Companies 255

Health Insurance Companies 255

STAT

OCTOBER 3, 2022

In August, the White House’s Office of Science and Technology Policy released a memo directing all federal agencies to form plans to make all federally funded research publications and data publicly available without embargo by the end of 2025. Most people who heard the news likely envisioned making a cup of coffee on Jan.

233

233

STAT

APRIL 23, 2024

facility to begin at the end of 2025, Reuters notes. Eli Lilly agreed to acquire a manufacturing facility from Nexus Pharmaceuticals to produce injectable medicines, and Lilly expects production at the Pleasant Prairie, Wi., Soaring demand for diabetes and obesity drugs has led to shortages for Lilly and Novo Nordisk. Last week, the U.S.

Diabetes 223

Diabetes 223

STAT

JULY 7, 2023

million older adults and other Medicare beneficiaries will save an estimated $400 per year in prescription drug costs in 2025 because of the president placing a cap on out-of-pocket spending as part of last year’s Inflation Reduction Act. Read the rest…

Hospitals 205

Hospitals 205

pharmaphorum

MARCH 1, 2024

The risk for those that don’t meet the 30th January 2025 deadline for transition is that they will lose their legal basis. There is a pressing need for companies to transition their EU clinical trials that are ongoing under the “old” regulatory framework of the Clinical Trials Directive to the Clinical Trials Regulation.

109

109

Pharmaceutical Technology

NOVEMBER 22, 2023

The funding will go towards the development of the company's four CNS candidates, with Phase II study data readouts expected by early 2025.

116

116